pharmacy benefit management - Search News

Pharmacy benefit managers inflated drug prices by $7.3B

Healthcare Dive · 1d

FTC releases second report slamming pharmacy benefit managers

Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the controversial drug middlemen as the agency’s first report released last summer — but relies on more data.

USA Today · 23h

FTC report shows $7.3 billion in drug price inflation by leading pharmacy benefit managers

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.

FTC report finds pharmacy benefit managers hiked prices of generic drugs

A new report by the Federal Trade Commission says pharmacy benefit management companies are driving up your out-of-pocket costs for prescription drugs.

Chicago Sun-Times · 13d

Pharmacy benefit managers have become too powerful

Pharmacy benefit managers make decisions about medication access that aren’t always based on the best interests of patients.

The Financial Times · 1d

FTC says pharmacy benefits managers marked-up generic drug prices for $7.3bn gain

Regulator’s report finds companies ‘hiked costs’ for a range of medicines, including cancer and HIV treatments

FTC doubles down on PBM criticism in new report

The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...

13d

Will Congress get another shot at PBM reform?

Click in for more news from The Hill{beacon} Health Care Health Care The Big Story Congress missed a chance at PBM reforms.

22hon MSN

UnitedHealth, employer of slain exec Brian Thompson, found to have overcharged some cancer patients for drugs by over 1,000%

CVS Caremark Rx blasted the findings for cherry picking certain drugs in an effort to push what it called an 'anti-PBM' ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results